Navigation Links
Cepheid Reports Second Quarter Revenue of $42.1 Million
Date:7/24/2008

ith no impact on product availability. We expect our product gross margin to return to first quarter levels in the current third quarter."

Operational Overview

-- Total product sales increased 65% to $39.0 million, from $23.6 million

in the second quarter of fiscal 2007. By industry, product sales

were, in millions:

Three Months Ended June 30

2008 2007 Change

Core Clinical $20.9 $6.1 239%

Clinical Partner 5.0 4.5 13%

Total Clinical 25.9 10.6 144%

Industrial 3.7 4.0 -7%

Biothreat 9.4 9.0 4%

Total Product Sales $39.0 $23.6 65%

-- System product sales increased 32% to $12.4 million from $9.4 million

in the second quarter of fiscal 2007.

-- Test and disposable sales increased 87% to $26.5 million from $14.2

million in the second quarter of fiscal 2007.

-- By geography, product sales were, in millions:

Three Months Ended June 30

2008 2007 Change

North America $29.7 $18.2 64%

Europe 9.0 5.1 74%

Rest of World 0.3 0.3 1%

Total Product Sales $39.0 $23.6 65%

Excluding biothreat revenue to the US Postal Service, North America sales increased 121% when compared to the same quarter a year ago.

-- During the quarter, Cepheid installed a total of 108 GeneXpert systems

and 426 modules, primarily in North America and Europe. As of June

30, 2008, a cumulative total of 717 GeneXpert systems and 3,560

modules have been placed worldwide.

-- GAAP gross margin on product sales was 41%
'/>"/>

SOURCE Cepheid
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Cepheid Enters Into Five-Year Agreement With Northrop Grumman for the Purchase of Anthrax Test Cartridges for Use in United States Postal Service Biohazard Detection Systems
2. Cepheid to Present at Thomas Weisel Partners Healthcare Conference
3. Cepheid Enters Agreement To Exclusively License HPV Portfolio Developed by Quantovir AB
4. Cepheid to Present at William Blair Small-Cap Growth Stock Conference
5. Cepheid to Present at the Piper Jaffray 19th Annual Healthcare Conference
6. Cepheid Receives Health Canada Medical Device License for Xpert MRSA(TM) Test and GeneXpert(R) System
7. Cepheid Schedules Teleconference and Webcast for 2007 Fourth Quarter and Full Year Results
8. Cepheid Appoints Senior VP, Chief Financial Officer to Management Team
9. Cepheid and Instrumentation Laboratory Introduce Xpert(TM) HemosIL(R) FII & FV Assay to European Clinical Testing Market
10. Cepheid Reports Fourth Quarter and Full Year 2007 Results
11. Cepheid to Present at Cowen and Companys 28th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)...  Caris Life Sciences ® , a leading ... precision medicine, today announced the presentation of data ... of Caris Molecular Intelligence ® , the company,s ... identify targeted treatment options for patients with rare ... results of which are to be presented in ...
(Date:5/29/2015)... RESEARCH TRIANGLE PARK, N.C. , May 29, 2015 ... today that Roger Jeffs , Ph.D., President and Co-Chief ... update on the company,s business at the Jefferies 2015 Global ... The presentation and the immediately following Q&A session ... AM Eastern Time, and can be accessed via a live ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 Seoul ... leader in LED technology, on May 28th announced ... market share by strengthening its high efficient and ... application , Since 2011 Seoul Semiconductor has developed ... lighting market and has supplied LEDs for headlamps ...
(Date:5/28/2015)... , May 28, 2015 ... announced the addition of Jain PharmaBiotech,s new ... and Companies"  to their offering.  ... remains a challenge in management. With nearly ... the seven major markets of the world ...
Breaking Biology Technology:Multi-Platform Tumor Profiling from Caris Life Sciences Identifies Targeted Treatment Options for Patients with Rare and/or Aggressive Tumors 2Multi-Platform Tumor Profiling from Caris Life Sciences Identifies Targeted Treatment Options for Patients with Rare and/or Aggressive Tumors 3Multi-Platform Tumor Profiling from Caris Life Sciences Identifies Targeted Treatment Options for Patients with Rare and/or Aggressive Tumors 4Multi-Platform Tumor Profiling from Caris Life Sciences Identifies Targeted Treatment Options for Patients with Rare and/or Aggressive Tumors 5Multi-Platform Tumor Profiling from Caris Life Sciences Identifies Targeted Treatment Options for Patients with Rare and/or Aggressive Tumors 6Seoul Semiconductor Increases the Global Automotive LED Market Share with its High Efficient and Reliable LEDs for Automotive Lightings 2Global Alzheimer Disease Report 2015-2024 - New Drugs, Markets and Companies 2Global Alzheimer Disease Report 2015-2024 - New Drugs, Markets and Companies 3
... LLC, a premier developer of innovative quality control products ... (PET) imaging, is pleased to announce the only ... of Standards and Technology (NIST) for accurate measurement of ... 1 millicurie (37 MBq) strength.  Fluorine-18 is an important ...
... Pharmaceuticals, Inc. (Nasdaq: ISIS ) announces the following ... Monday, February 28, 2011 at 4:30 p.m. ET / 1:30 ... log onto our Web site listed above. If you are ... the webcast will be available for a limited time at ...
... NEW YORK and SAN DIEGO, Feb. 14, 2011 Polaris ... today announced the enrollment of the first patient in a ... of small cell lung cancer (SCLC).  The trial, sponsored by ... Duke University Medical Center and will soon commence at St. ...
Cached Biology Technology:RadQual, LLC Announces a New Industry Leading Dose Calibrator Reference Standard 2Polaris Group and The Ludwig Institute for Cancer Research Ltd Initiate Phase 2 Trial of Amino-Acid Degrading Enzyme, ADI-PEG 20, in Patients with Small Cell Lung Cancer 2Polaris Group and The Ludwig Institute for Cancer Research Ltd Initiate Phase 2 Trial of Amino-Acid Degrading Enzyme, ADI-PEG 20, in Patients with Small Cell Lung Cancer 3
(Date:4/27/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... the growing mobile commerce market, announces that its Wocket® ... first week of May, 2015 and will be fulfilling ... Gino Pereira , Chief Executive Officer ... as Wocket® enters the consumer market. We would like ...
(Date:4/20/2015)... , April 20, 2015 Huntington Memorial Hospital ... to implant a new miniaturized, wireless monitoring sensor to ... the first and only FDA-approved heart failure monitoring device ... when used by physicians to manage heart failure. ... is implanted in the pulmonary artery (PA) during a ...
(Date:4/14/2015)...  HYPR Corp. today announced it has joined ... tm , an industry consortium transforming online authentication ... technology and collaborate to deliver open specifications for ... and private, and easier to use. ... sensitive user information and eliminates the dependency on ...
Breaking Biology News(10 mins):Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3
... New article postings for Geology cover glacial erosion ... changing the face of Earth; collisional shortening in the ... typhoon Morakot in 2009; a new type of iron ... using fossil marine plankton records in 70-million-year-old sediments as ...
... chemical sensors for your iPhone, and new materials with ... power, and new crime scene investigation techniques this month ... materials, interfaces, and processing. Detailed press releases will follow ... & Exhibition will take place Oct. 27 - Nov. ...
... Michael J. Fox Foundation for Parkinson,s Research and Shake ... project by Sydney,s Garvan Institute of Medical Research to ... Parkinson,s disease. Long non-coding RNAs are complex molecules, ... regulatory roles in the body. Unlike conventional genes, they ...
Cached Biology News:Glacial buzz-saws, gold in fool's gold, fingerprints in sea water, and fluvial iron 2Glacial buzz-saws, gold in fool's gold, fingerprints in sea water, and fluvial iron 3Glacial buzz-saws, gold in fool's gold, fingerprints in sea water, and fluvial iron 4Glacial buzz-saws, gold in fool's gold, fingerprints in sea water, and fluvial iron 5Glacial buzz-saws, gold in fool's gold, fingerprints in sea water, and fluvial iron 6Glacial buzz-saws, gold in fool's gold, fingerprints in sea water, and fluvial iron 7Glacial buzz-saws, gold in fool's gold, fingerprints in sea water, and fluvial iron 8Glacial buzz-saws, gold in fool's gold, fingerprints in sea water, and fluvial iron 9AVS science symposium in Long Beach Oct. 27 -- Nov. 2 2Garvan Institute receives grant to research role of long non-coding RNAs in Parkinson's disease 2
... paraffin tissue array is designed for ... interest in extensive panels of different ... heart, kidney, liver, lung, muscle, spleen ... positively charged glass slide. Each ...
EPH electrode, anode, 1. Category: Electrophoresis Systems & Standards & Reagents, IEF & SDS-PAGE & 2-D Electrophoresis, Multiphor II Kits & Components and Accessories....
LIVE/DEAD® Sperm Viability Kit *200-1000 assays*...
in vitro Translation, Accessory Products...
Biology Products: